|
|
Antacids | |
|
Alcohol Bacopa Lithium (prescription) Lithium (supplements) | |
| Depletion or interference |
None known |
| Side effect reduction/prevention |
None known |
| Supportive interaction |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
Lithium
Lithium is a mineral that may be present in some supplements and is also used in large amounts
to treat mood disorders, such as bipolar disorder. Taking lithium at the same time as
phenothiazines may result in drug side effects such as disorientation and
unconsciousness.1 Though no studies have investigated whether the small amount of
lithium available in supplements might interact with prochlorperazine to cause similar
effects, people taking the drug should exercise caution when supplementing with lithium.
Bacopa
An animal study found that the effects of chlorpromazine, a drug similar to (perphenazine,
prochlorperazine, thioridazine), were enhanced when a bacopa extract was given along with
it.2 Until more is known, people taking medications from this family of drugs
(called phenothiazines) should not take bacopa.
Alcohol
Taking prochlorperazine may increase or prolong the effects of alcohol, such as drowsiness,
dizziness, and poor coordination.3 Therefore, people taking prochlorperazine should
avoid drinking alcohol, especially when they must stay alert.
Antacids
Many antacid products contain aluminium
hydroxide, which reduces the absorption of phenothiazine drugs.4 Though no
studies are available that confirm an interaction between prochloroperazine and antacids,
people who are using antacids should take them an hour before or two hours after the drug.
1. Burnham TH, ed. Central Nervous System Agents, Antipsychotic Agents. In Drug Facts and Comparisons. St. Louis, MO: Facts and Comparisons, 2001, 945–65.
2. Ganguly DK, Malhotra CL. Some behavioral effects of an active fraction from Herpestis monniera Linn. (Brahmi). Indian J Med Res 1967;55:473–82.
3. Sifton DW, et. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., 2000, 2986–8.
4. Burnham TH, ed. Central Nervous System Agents, Antipsychotic Agents. In Drug Facts and Comparisons. St. Louis, MO: Facts and Comparisons, 2001, 945–65.
| |||||||